Journal article · 2014 · Open access

Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial

Norio Watanabe, Toshi A. Furukawa, Shinji Shimodera, Fujika Katsuki, Hirokazu Fujita, Megumi Sasaki, Mitsuhiro Sado, Michael Lloyd Perlis

Psychiatry and Clinical Neurosciences, 69(6), 335–343 · Published 10 September 2014 · DOI 10.1111/pcn.12237

Open PDFView at the publisherCite this paper

In brief

“Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial” is a 2014 journal article by Norio Watanabe and 7 co-authors, published in Psychiatry and Clinical Neurosciences. OpenAlex counts 44 citations as of 20 November 2026. It is open access: the full text is free to read at Psychiatry and Clinical Neurosciences.

Citations
44
Most cited in
2023 (6)
Field-weighted impact
1.85
References
27
Authors
8

Abstract

AIM: Although the efficacy of cognitive behavioral therapy for insomnia has been confirmed, dissemination depends on the balance of benefits and costs. This study aimed to examine the cost-effectiveness of cognitive behavioral therapy for insomnia consisting of four weekly individual sessions. METHODS: We conducted a 4-week randomized controlled trial with a 4-week follow up in outpatient clinics in Japan. Thirty-seven patients diagnosed as having major depressive disorder according to DSM-IV and suffering from chronic insomnia were randomized to receive either treatment as usual (TAU) alone or TAU plus cognitive behavioral therapy for insomnia. Effectiveness was evaluated as quality-adjusted life years (QALY) over 8 weeks' time, estimated by bootstrapping of the observed total scores of the Hamilton Depression Rating Scale. Direct medical costs for cognitive behavioral therapy for insomnia and TAU were also evaluated. We calculated the incremental cost-effectiveness ratio. RESULTS: Over the 8 weeks of the study, the group receiving cognitive behavioral therapy for insomnia plus TAU had significantly higher QALY (P = 0.002) than the TAU-alone group with an incremental value of 0.019 (SD 0.006), and had non-significantly higher costs with an incremental value of 254 (SD 203) USD in direct costs. The incremental cost-effectiveness ratio was 13 678 USD (95% confidence interval: -5691 to 71 316). Adding cognitive behavioral therapy for insomnia demonstrated an approximately 95% chance of gaining one more QALY if a decision-maker was willing to pay 60 000 USD, and approximately 90% for 40 000 USD. CONCLUSION: Adding cognitive behavioral therapy for insomnia is highly likely to be cost-effective for patients with residual insomnia and concomitant depression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Watanabe, N., Furukawa, T. A., Shimodera, S., Katsuki, F., Fujita, H., Sasaki, M., Sado, M., & Perlis, M. L. (2014). Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial. Psychiatry and Clinical Neurosciences, 69(6), 335–343. https://doi.org/10.1111/pcn.12237

MLA 9

Watanabe, Norio, et al. “Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.” Psychiatry and Clinical Neurosciences, vol. 69, no. 6, 2014, pp. 335–343. https://doi.org/10.1111/pcn.12237.

Chicago

Watanabe, Norio, Toshi A. Furukawa, Shinji Shimodera, Fujika Katsuki, Hirokazu Fujita, Megumi Sasaki, Mitsuhiro Sado, and Michael Lloyd Perlis. 2014. “Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.” Psychiatry and Clinical Neurosciences 69 (6): 335–343. https://doi.org/10.1111/pcn.12237.

Harvard

Watanabe, N. et al. (2014) ‘Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial’, Psychiatry and Clinical Neurosciences, 69(6), pp. 335–343. doi:10.1111/pcn.12237.

IEEE

N. Watanabe et al., “Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial,” Psychiatry and Clinical Neurosciences, vol. 69, no. 6, pp. 335–343, 2014, doi: 10.1111/pcn.12237.

BibTeX

@article{watanabe2014cost,
  title     = {{Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial}},
  author    = {Watanabe, Norio and Furukawa, Toshi A. and Shimodera, Shinji and Katsuki, Fujika and Fujita, Hirokazu and Sasaki, Megumi and Sado, Mitsuhiro and Perlis, Michael Lloyd},
  journal   = {Psychiatry and Clinical Neurosciences},
  year      = {2014},
  volume    = {69},
  number    = {6},
  pages     = {335--343},
  doi       = {10.1111/pcn.12237},
  url       = {https://doi.org/10.1111/pcn.12237}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
201833
201933
202022
202144
202255
202366
202433
202566
202644

Its field-weighted citation impact is 1.85: it has been cited 1.85 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders

  • cognitive behavioral therapy for insomnia
  • insomnia
  • major depressive disorder
  • comorbidities
  • cost-effectiveness
  • quality-adjusted life years
  • incremental cost-effectiveness ratio
  • direct medical costs

Work with this paper

Most-cited papers in Psychology

All highly cited Psychology papers

Questions about this paper

How do I cite this paper in APA style?

Watanabe, N., Furukawa, T. A., Shimodera, S., Katsuki, F., Fujita, H., Sasaki, M., Sado, M., & Perlis, M. L. (2014). Cost‐effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial. Psychiatry and Clinical Neurosciences, 69(6), 335–343. https://doi.org/10.1111/pcn.12237

How many times has this paper been cited?

44 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Psychiatry and Clinical Neurosciences: sign in and open the PDF from this page.

Who wrote this paper?

Norio Watanabe, Toshi A. Furukawa, Shinji Shimodera, Fujika Katsuki, Hirokazu Fujita, Megumi Sasaki, Mitsuhiro Sado, Michael Lloyd Perlis.

What is the DOI of this paper?

10.1111/pcn.12237, permanently at https://doi.org/10.1111/pcn.12237. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.